Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
about
Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trialTherapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studiesFamilial hypercholesterolemia: present and future managementJTT-705: is there still future for a CETP inhibitor after torcetrapib?Cholesteryl ester transfer protein, coronary calcium, and intima-media thickness of the carotid artery in middle-age Japanese men.A role for CETP TaqIB polymorphism in determining susceptibility to atrial fibrillation: a nested case control studyAssociation of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community.CETP inhibitors and cardiovascular disease: Time to think again.Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective studyCholesteryl ester transfer protein, low density lipoprotein particle size and intima media thickness in patients with coronary heart disease.Molecular regulation of HDL metabolism and function: implications for novel therapies.Novel HDL-directed pharmacotherapeutic strategies.Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease.Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control studyCardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.High-density lipoprotein cholesterol: a potential therapeutic target for prevention of coronary artery disease.CETP inhibition in cardiovascular risk management: a critical appraisal.High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.HIV infection and high density lipoprotein metabolismPlasma lipid transfer proteins and cardiovascular disease. The Framingham Heart StudyFarnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic miceViability of developing CETP inhibitors.Plasma lipid transfer enzymes in non-diabetic lean and obese men and womenCommon variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis.High-density lipoprotein: a fall from grace?Apolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma.Is high HDL cholesterol always good?Cholesteryl ester transfer protein (CETP) genetic variation and early onset of non-fatal myocardial infarction.Advancing therapy for hypercholesterolemia.Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.Evacetrapib.Lipid pharmacotherapy for treatment of atherosclerosis.Ongoing challenges for pharmacotherapy for dyslipidemia.The controversy over the use of cholesteryl ester transfer protein inhibitors: is there some light at the end of the tunnel?CETP Inhibition in CVD Prevention: an Actual Appraisal.Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits.Assessing the clinical utility of biomarkers in medicine.Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study.Cholesteryl ester transfer protein alters liver and plasma triglyceride metabolism through two liver networks in female miceNo clinically relevant drug-drug interactions when dalcetrapib is co-administered with atorvastatin.
P2860
Q24648125-757C32E0-EBCC-4F50-BB1F-DB5F89284E67Q26738588-C71C028C-F92F-4C05-9601-DFC998EB746DQ26828489-A1F00B16-A848-4F02-8B02-6B5729752536Q28294797-39C8044C-C7EE-476F-9272-58E3334F7B4EQ30436835-3A92233F-4643-4672-BCF9-01C06F6263F7Q33240337-A20D5866-0F40-47A6-A4E0-95DCE940BCD2Q33639433-4C3DE953-37A0-43E9-A788-7590BD660D18Q34109100-1A3E79FE-5A91-4821-817F-3486E6055E8CQ34339500-229FB1B1-D939-43FB-BBBB-35FBF9F3BDDFQ35184658-9730620C-215E-4134-9EFD-AD7AE6F0AB26Q35191066-DD292D1B-349C-4070-9BD5-3B07CE116C7CQ35860020-931D8C86-84FE-458D-B58E-E3AD725FBA1AQ35958497-7DE0975D-9C89-4894-AE25-B9A321445C82Q36287533-345FF41B-2603-414F-B860-77E707AE11B0Q36419283-0597F35D-69A8-434B-9A53-C21B155C5BD7Q36704247-08E63345-8DB6-4FED-80E7-553BAA020C48Q36705260-3FBB230C-45E9-4515-9CAF-AEC57D70AE3FQ36766976-468B7738-EFF9-493A-91D3-6820015A34FAQ36841647-CF38596D-135E-40DC-B390-918CD938872BQ36953767-94DACABE-65C9-4FD6-840D-1701F51D5A77Q37002680-C4DEEFF8-2CC8-46E0-9FF5-EB15CBDE13EEQ37165682-51C75C61-790B-4BF3-8F27-6C4A529E2BBAQ37176924-41E3996F-573C-426F-86A4-1C633E1CE841Q37179542-E0E0A910-C936-4ADB-B467-1CF0FF2931B7Q37209767-3756B66E-A0B4-4083-A234-79B00A67E121Q37299858-C0F1EA75-2BDB-4700-8FEE-719385397F10Q37351659-6383B8F2-31BF-48FC-86E6-E35E7783E89DQ37398234-E480FD08-BC9A-452E-8BDE-3F5F120EEE59Q37761373-BFCED1F1-815F-4305-98ED-DCFE3D067887Q37774393-77F94B7F-1C02-464E-8715-D9ACE79403DEQ37987837-1D2A8A7C-0AD0-4E6A-AD93-97AFDDF0B341Q38202198-F467C135-2438-4F81-9329-08475FA675EAQ38283386-64FD4BA0-28FA-4447-B6B6-0884C470316CQ38780552-8445910E-090A-4FA9-A869-A82C00DE2CEBQ38784639-66F3F96C-3842-4EE9-9D10-E4F3F2241759Q40166036-92C9C024-1BAB-481E-BB7A-0C2DC9A22F68Q40169397-193F51F2-0247-46A2-B843-6BCAFB9FFD3AQ40301622-F7AA954D-542E-4012-B9C3-26C5CF35EE01Q41826140-CCF7F75A-E358-409A-82C9-D6339E225043Q42926221-CCC6A51E-E71B-4189-9C5A-3E5BF593F815
P2860
Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Plasma levels of cholesteryl e ...... ion)-Norfolk population study.
@en
type
label
Plasma levels of cholesteryl e ...... ion)-Norfolk population study.
@en
prefLabel
Plasma levels of cholesteryl e ...... ion)-Norfolk population study.
@en
P2093
P50
P1433
P1476
Plasma levels of cholesteryl e ...... ion)-Norfolk population study.
@en
P2093
J Wouter Jukema
Jan-Albert Kuivenhoven
John J P Kastelein
Nicholas E Day
Ron J G Peters
S Matthijs Boekholdt
Sheila A Bingham
P304
P356
10.1161/01.CIR.0000141730.65972.95
P407
P577
2004-08-30T00:00:00Z